Methyllysine post-translational modifications (PTMs) of histones create binding sites for evolutionarily conserved reader domains that link nuclear host proteins and chromatin-modifying complexes to specific genomic regions. In the context of these events, adjacent histone PTMs are capable of altering the binding activity of readers toward their target marks. This provides a mechanism of "combinatorial readout" of PTMs that can enhance, decrease, or eliminate the association of readers with chromatin. In this Perspective, we focus on recent studies describing the impact of dynamic phospho-serine/threonine/tyrosine marks on the interaction of methyllysine readers with histones, summarize mechanistic aspects of the phospho/methyl readout, and highlight the significance of crosstalk between these PTMs. We also demonstrate that in addition to inhibiting binding and serving as a true switch, promoting dissociation of the methyllysine readers from chromatin, the phospho/methyl combination can act together in a cooperative manner--thus adding a new layer of regulatory information that can be encoded in these dual histone PTMs.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861070PMC
http://dx.doi.org/10.1021/acschembio.5b00802DOI Listing

Publication Analysis

Top Keywords

methyllysine readers
12
histone ptms
8
readers chromatin
8
readers
5
ptms
5
regulation methyllysine
4
readers phosphorylation
4
phosphorylation methyllysine
4
methyllysine post-translational
4
post-translational modifications
4

Similar Publications

Sulfonium is an electrophilic and biocompatible group that is widely applied in synthetic chemistry on small molecules. However, there have been few developments of peptide or protein-based sulfonium tools. We recently reported sulfonium-mediated tryptophan crosslinking and developed NleSme2 (norleucine-dimethylsulfonium) peptides as dimethyllysine mimics that crosslink site-specific methyllysine readers.

View Article and Find Full Text PDF

Tudor-Containing Methyl-Lysine and Methyl-Arginine Reader Proteins: Disease Implications and Chemical Tool Development.

ACS Chem Biol

January 2025

UNC Eshelman School of Pharmacy, Center for Integrative Chemical Biology and Drug Discovery, Chemical Biology and Medicinal Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.

Tudor domains are histone readers that can recognize various methylation marks on lysine and arginine. This recognition event plays a key role in the recruitment of other epigenetic effectors and the control of gene accessibility. The Tudor-containing protein family contains 42 members, many of which are involved in the development and progression of various diseases, especially cancer.

View Article and Find Full Text PDF

Selective photo crosslinking to methylarginine readers by sulfonium peptides.

Bioorg Med Chem

February 2025

Department of Chemistry, School of Science, Westlake University, Hangzhou 310030, Zhejiang Province, China; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou 310024, Zhejiang Province, China; Institute of Natural Sciences, Westlake Institute for Advanced Study, Hangzhou 310024, Zhejiang Province, China. Electronic address:

Arginine methylation is an important posttranslational modification that regulates epigenetics and pre-mRNA splicing. Similar to lysine methylation, reader proteins that bind site-specific modified proteins are key mediators for arginine methylation functions. Some arginine methylation has been shown significant functions from phenotype, but the molecular mechanisms remain elusive, probably due to lack of identification of the readers.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers have identified an important class of proteins known as "readers" that detect modified residues in proteins, which helps explain the roles of post-translational modifications.
  • Current methods for studying these readers typically use complicated photoreactive agents that can cause unwanted crosslinking.
  • The new approach involves using dimethylsulfonium as a safe methyllysine mimic to selectively crosslink with specific readers, enhancing the ability to discover these readers in complex biological samples and enabling the development of new strategies for targeting specific sites in proteins.*
View Article and Find Full Text PDF

Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor.

J Med Chem

April 2024

Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States.

Article Synopsis
  • The SPIN1 protein, which reads methyl-lysine marks, is critical in various human diseases but has proven difficult to target due to a lack of effective inhibitors.
  • Research led to the discovery of two new compounds: one that selectively inhibits SPIN1 and another that targets both SPIN1 and G9a/GLP, with the latter displaying high selectivity over other epigenetic targets.
  • The study confirmed the binding of the dual inhibitor to a specific domain of SPIN1 and showed its effectiveness in disrupting SPIN1 interactions in cells, along with being bioavailable in mice, providing valuable tools for studying SPIN1's biological functions.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!